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A B S T R A C T
Background
Dysmenorrhoea refers to the occurrence of painful menstrual cramps of uterine origin and is a common gynaecological condition with
considerable morbidity. The behavioural approach assumes that psychological and environmental factors interact with, and influence,
physiological processes. Behavioural interventions for dysmenorrhoea may include both physical and cognitive procedures and focus
on both physical and psychological coping strategies for dysmenorrhoeic symptoms rather than modification of any underlying organic
pathology.
Objectives
To determine the effectiveness of any behavioural interventions for the treatment of primary or secondary dysmenorrhoea when
compared to each other, placebo, no treatment, or conventional medical treatments for example non-steroidal anti-inflammatory drugs
(NSAIDs).
Search methods
We searched the CochraneMenstrual Disorders and Subfertility Group Trials Register (searchedMay 2009), Cochrane Central Register
of Controlled Trials (CENTRAL on The Cochrane Library, Issue 2, 2009), MEDLINE (1966 to May 2009), EMBASE (1980 to May
2009), Social Sciences Index (1980 to May 2009), PsycINFO (1972 to May 2009) and CINAHL (1982 to May 2009) and reference
lists of articles.
Selection criteria
Randomised controlled trials comparing behavioural interventions with placebo or other interventions in women with dysmenorrhoea.
Data collection and analysis
Two authors independently assessed trial quality and extracted data.
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Main results
Five trials involving 213 women were included.
Behavioural intervention vs control: One trial of pain management training reported reduction in pain and symptoms compared to
a control. Three trials of relaxation compared to control reported varied results, two trials showed no difference in symptom severity
scores however one trial reported relaxation was effective for reducing symptoms in menstrual sufferers with spasmodic symptoms. Two
trials reported less restriction in daily activities following treatment with either relaxation of pain management training compared to a
control. One trial also reported less time absent from school following treatment wit pain management training compared to a control.
Behavioural intervention vs other behavioural interventions: Three trials showed no difference between behavioural interventions
for the outcome of improvement in symptoms. One trial showed that relaxation resulted in a decrease in the need for resting time
compared to the relaxation and imagery.
Authors’ conclusions
There is some evidence from five RCTs that behavioural interventions may be effective for dysmenorrhoea. However results should be
viewedwith caution as they varied greatly between trials due to inconsistency in the reporting of data, small trial size, poormethodological
quality and age of the trials.
P L A I N L A N G U A G E S U M M A R Y
Behavioural interventions for dysmenorrhoea
Dysmenorrhoea is a very common complaint that refers to painful menstrual cramps in the uterus (womb). When the pain is due to a
recognised medical condition such as endometriosis it is called secondary dysmenorrhoea.When the pain is of unknown cause it is called
primary dysmenorrhoea. Nonsteroidal anti-inflammatory drugs or the contraceptive pill have been used as treatment for period pain
but more women are looking for non-drug therapies. Behavioural therapies assume that psychological (the mind) and environmental
factors interact with, and influence, physical processes, for example stress might influence period pain. Behavioural therapies focus
on both physical and psychological coping strategies for symptoms such as pain rather than focusing on medical solutions for any
underlying causes of the symptoms. An example of a behavioural therapy is using relaxation to help a woman cope with painful period
cramps. This review found that progressive muscle relaxation with or without imagery and relaxation may help with spasmodic (acute,
cramping pain) symptoms of period pain. Also that pain management training and relaxation plus biofeedback may help with period
pain in general. The results are not conclusive due to the small number of women in the trials and the poor methods used in some of
the trials.
B A C K G R O U N D
Description of the intervention
The aetiology of primary dysmenorrhoea has been the source of
considerable debate. Until quite recently, many medical and gy-
naecological texts ascribed the source of primary dysmenorrhoea
as emotional or psychological problems. Dysmenorrhoea was at-
tributed to a variety of ca such as anxiety, emotional instability,
a faulty outlook on sex and menstruation, or imitation of the
mother’s feelings about menstruation (Jeffcoate 1975). It has also
been attributed topsychoanalytic principles such as rejection of the
feminine role or failure to conceive resulting in a frustrated “weep-
ing” uterus (Ylikorkala 1978). Experimental and clinical research
has identified physiological reasons for dysmenorrhoea; the over-
production of uterine prostaglandins, which are associated with
uterine contractions (Rosenwaks 1980), and the over-production
of vasopressin, a hormone that also stimulates the contraction of
muscular tissue (Stromberg 1984).
Since the implication of physiological factors in the aetiology of
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dysmenorrhoea, conventional treatment has focused on medical
therapy. Nonsteroidal anti-inflammatory drugs (NSAIDs), which
work as prostaglandin synthetase inhibitors, and oral contracep-
tive pills, which inhibit ovulation thus reducing myometrial ac-
tivity, are now considered standard treatments (Dawood 1988;
Dawood 1990). The efficacy of these conventional treatments is
high, however the failure rate is still around 20 to 25% (Dawood
1985; Henzl 1985). Therefore there is a need for alternatives to
the conventional medical treatments.
How the intervention might work
Behavioural interventions have been shown to be effective in man-
aging pain in fields as diverse as osteoarthritis and cancer (Bradley
1998; Syrjala 1995). A recent National Institutes of Health (NIH)
Consensus Development Conference also found behavioural and
relaxation approaches useful in the treatment of chronic pain (NIH
Panel 1996). The behavioural approach assumes that psycholog-
ical and environmental factors interact with and influence physi-
ological processes. Research has demonstrated that life stress can
influence dysmenorrhoea, which lends some evidence to the be-
havioural approach for this type of disorder (Marini 1978; Siegel
1979). A variety of interventions are labelled as behavioural and it
is difficult to provide a single definition. Behavioural interventions
are primarily aimed at modifying an individual’s behaviour but
can also be aimed at modifying thoughts or cognitions in order to
subsequently change behaviour. Behavioural interventions for dys-
menorrhoea may include both physical and cognitive procedures
such as biofeedback, desensitization based procedures, Lamaze ex-
ercises, hypnotherapy, and relaxation training (Denny 1981; Lewis
1983). These type of interventions focus on physical and psycho-
logical coping strategies for dysmenorrhoeic symptoms rather than
modification of any underlying organic pathology. Case studies
suggest that behavioural interventions may be effective in treating
dysmenorrhoea, although it is difficult to evaluate these types of
studies due to small numbers of participants and poor methodol-
ogy (Denny 1981).
Why it is important to do this review
More and more individuals are seeking alternatives to medical
interventions. This review aim to explore the role of behavioural
interventions for dysmenorrhoea.
O B J E C T I V E S
To determine the effectiveness of any behavioural interventions
for the treatment of primary or secondary dysmenorrhoea when
compared to each other, placebo, no treatment, or conventional
medical treatments for example non-steroidal anti-inflammatory
drugs( NSAIDs).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Any randomised controlled trials (RCTs) that use behavioural in-
terventions to treat primary or secondary dysmenorrhoea.
Types of participants
Inclusion criteria:
Participants in the trials had to meet these inclusion criteria for
the trial to be included in the review
• women of reproductive age;
• women with moderate to severe primary dysmenorrhoea
(pain that does not respond well to analgesics, affects daily
activity or has a high baseline score on a validated pain scale) or
women with secondary dysmenorrhoea of identifiable pathology.
Trials where the severity of dysmenorrhoea was not formally
assessed were included if the potential participants had sought
medical advice for perceived pain;
• women with self-reported dysmenorrhoea in the majority
of menstrual cycles.
Exclusion criteria:
If participants in the trial met any of these exclusion criteria the
trial was not included in the review
• women with mild dysmenorrhoea (mild pain that responds
to analgesics);
• women with irregular/infrequent menstrual cycles (outside
of the typical range of a 21-35 day cycle);
• women using an intra-uterine contraceptive device (IUD)
or taking oral contraceptive pills (OCP).
Types of interventions
Any RCTs involving behavioural interventions as treatment for
primary or secondary dysmenorrhoea versus each other, placebo,
no treatment, other types of control groups (e.g.wait lists) or other
conventional treatment were considered for inclusion in the re-
view.
A variety of interventions have been labelled behavioural interven-
tions and it is difficult to provide a single, unambiguous defini-
tion.
This review included interventions which;
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(i) attempt modification of thought and beliefs (cognitions) about
symptoms and pain. Examples of interventions would be desen-
sitization based procedures, hypnotherapy, imagery, and coping
strategies, and/or
(ii) attempt modification of behavioural (or physiological) re-
sponses to symptoms and pain. Examples of interventions would
be biofeedback (training that develops an individual’s ability to
control their autonomic nervous system, for example heart rate),
EMG (electromyographic) training (use of a graphic representa-
tion of muscle contractions to learn to control them), Lamaze ex-
ercises, and relaxation training.
Interventions could include those aimed at reducing the pain of
dysmenorrhoea as well as those aimed at improving a participant’s
ability to cope with dysmenorrhoea. Regardless of the focus of
the intervention the same outcome measures were assessed for all
included trials.
Exercise as an single interventionwas not considered for this review
as it is the subject of another review (Bolton 2003).
Types of outcome measures
Primary outcomes
• Pain relief (measured either by visual analogue scale (VAS),
other scales, or dichotomous outcomes (i.e. pain relief yes/no)).
• Overall improvement in symptoms (measured by change in
dysmenorrhoeic symptoms, either self-reported or investigator-
observed treatment effectiveness, or any other similar measures).
• Adverse effects from treatment (incidence of side effects and
type of side effects).
Secondary outcomes
• Requirements for medication additional to assigned
treatment (measured as a proportion of women requiring
analgesics additional to their assigned treatment).
• Restriction of daily life activities (measured as a proportion
of women of women who report activity restriction).
• Absence from work or school (measured as a proportion of
women reporting absences from work or school, and also as
hours/days of absence as a more selective measure).
Search methods for identification of studies
Electronic searches
Electronic searches
We searched the Cochrane Menstrual Disorders and Subfertility
Group Trials Register (search updated May 2009) (Appendix 1),
MEDLINE (1966 to May 2009)(Appendix 2), Cochrane Central
Register of Controlled Trials (CENTRAL on The Cochrane Li-
brary, Issue 2, 2009)(Appendix 3), EMBASE (1980 toMay 2009)
(Appendix 4) and PsycINFO (1972 to May 2009)(Appendix 5)
for publications which described randomised trials of behavioural
interventions in the treatment of dysmenorrhoea.
Searching other resources
The National Research Register (NRR), a register of ongoing and
recently completed research projects funded by, or of interest to,
the United Kingdom’s National Health Service, as well as entries
from the Medical Research Council’s Clinical Trials Register, and
details on reviews in progress collected by the NHS Centre for
Reviews and Dissemination, was searched for any trials with dys-
menorrhoea or dysmenorrhoea as a keyword. Clinical Trials reg-
ister, a registry of both federally and privately funded US clinical
trials was also searched for the same keywords.
The Cochrane Complementary Medicine Field’s register of con-
trolled trials (CISCOM) was also searched for any trials with dys-
menorrhoea or dysmenorrhoea in the title, abstract or keyword
fields.
The citation lists of relevant publications, review articles, and in-
cluded studies were also searched.
Data collection and analysis
Selection of studies
The selection of trials for inclusion in the review was performed by
two of the review authors (MP and PM) after employing the search
strategy described previously. The titles and abstracts of potential
trials were checked against the inclusion criteria.
Data extraction and management
Data extraction was performed by two of the review authors (MP
andPM) independently. Any discrepancies were to be resolved by a
third review author (CF), however this was unnecessary. Included
trials were analysed for the following details. This information is
presented in the table of characteristics of included studies and
provides a context for discussing the reliability of results:
Trial characteristics
1. Method of randomisation
2. Presence or absence of blinding to treatment allocation
3. Quality of allocation concealment
4. Number of participants randomised, excluded or lost to follow
up
5. Whether an intention to treat analysis was done
6. Whether a power calculation was done
7. Duration, timing and location of the study
8. Source of participants (i.e. where/how they were recruited)
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Characteristics of the study participants
1. Age and any other recorded characteristics of women in the
study
2. Other inclusion criteria
3. Exclusion criteria
4. Methods used to define and diagnose study participants
Interventions used
1. Type of behavioural intervention
2. Type of placebo/control
3. Type of behaviour change targeted
Outcomes
1. Methods used to measure pain relief achieved by treatment
2. Methods used to measure overall improvement in dysmenor-
rhoea
3. Methods used to measure requirements for additional medica-
tion
4. Methods used to measure restriction of daily life activities
5. Methods used to measure absence from work or school
6. Information on any other outcomes related to the specific in-
tervention used
Assessment of risk of bias in included studies
Figure 1; Figure 2
All assessments of the quality of trials were performed indepen-
dently by two of the review authors (MW and HP). Any discrep-
ancies were to be resolved by a third review author (CF), however
this was unnecessary. All included trials were assessed for method-
ological quality with the following list of questions. No formal
score was used however the results were used to provide a context
in discussing the reliability and validity of results.
Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Methodological quality assessment questions
• Was the assigned treatment adequately concealed prior to
allocation?
• Were the outcomes of patients who withdrew or were
excluded after allocation described and included in an ’intention
to treat’ analysis?
• Were the withdrawals <15% of the study population
• Were the inclusion and exclusion criteria for entry clearly
defined?
• Were the treatment and control group comparable at entry?
• Were the subjects blind to assignment status following
allocation (if trial design allowed it)?
• Were the treatment providers blind to assignment status (if
trial design allowed it)?
• Were the care programmes, other than the trial options,
identical?
• Were there any checks to ensure compliance to treatment?
• Were the outcome assessors blind to assignment status?
• Were the outcome measures used clearly defined?
• Were the accuracy, precision, and observer variation of the
outcome measures adequate?
• Was the timing of the outcome measures appropriate?
• Were the outcome measures clearly reported?
Additional information on trial methodology or actual original
trial data were sought from the authors of four of the included trials
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in order to clarify aspects of methodology or when data were un-
suitable for inclusion in themeta-analysis (Amodei 1987; Chesney
1975; Hart 1981; Quillen 1982). Replies were not received from
any of the authors. Letters were not sent to the other study as
recent addresses for the authors could not be located (Bennink
1982).
Measures of treatment effect
Each type of behavioural intervention was analysed separately. Sta-
tistical analysis was performed in accordance with the guidelines
for statistical analysis developed by the Menstrual Disorders and
Subfertility Group. It was intended for outcomes to be pooled sta-
tistically. However due to the small number of trials and variety of
interventions this was not possible. Heterogeneity between the re-
sults of different studies was to have been examined by inspecting
the scatter in the data points and the overlap in their confidence
intervals and, more formally by checking the results of the chi-
squared tests.
A priori, it was planned to perform sensitivity analyses on results
to look at the possible contribution of:
(1) differences inmethodological quality, trials of high quality only
compared to all trials
(2) differences in methods of assessing dysmenorrhoeic pain, use
of VAS compared to other scales
However these analyses were not possible as only five trials were
included, an inadequate number for these type of analyses.
For dichotomous data (for example, proportion of participants
with a specific adverse side effect), results for each study were ex-
pressed as an odds ratio with 95% confidence intervals and com-
bined for meta-analysis with RevMan software using the Peto-
modified Mantel-Haenszel method.
Continuous differences between groups in the meta-analysis (for
example, pain relief on a visual analogue scale) was shown as a
weighted mean difference (WMD) and 95% confidence interval.
A fixed effects model was used.
Timing of updates
It is the intention of the review authors that no further updates
are required for this review.
R E S U L T S
Description of studies
Results of the search
Thirteen trials were initially identified. Three were excluded
(Hubbell 1949; Israel 1985; Lundquist 1947) as they included
exercise which is an intervention to be considered by another
Cochrane review (Bolton 2003). A further three trials were ex-
cluded as their participants were not women with dysmenorrhoea
(Pearce 1982; Peters 1991; Van Zak 1994). Two were excluded for
failing to mention whether they were randomised (Mathur 1986;
Sigmon 1988): data were sought from the authors but no reply
was received. Therefore five trials were included in the review (see
Included Studies table) (Amodei 1987; Bennink 1982; Chesney
1975; Hart 1981; Quillen 1982).
Types of participants
Three of the included studies categorised the type of dysmenor-
rhoea as congestive (dull, aching pain) or spasmodic (acute, col-
icky pain) using theMenstrual SymptomsQuestionnaire (Amodei
1987; Bennink 1982; Quillen 1982). These labels were developed
as subgroups of primary dysmenorrhoea, although only two of
these trials also mentioned excluding organic causes of dysmen-
orrhoea (Bennink 1982; Quillen 1982). One of these trials also
only included women with spasmodic dysmenorrhoea (Bennink
1982). One trial specified women with primary dysmenorrhoea
with no other inclusion or exclusion criteria (Hart 1981), and
the last mentioned women with menstrual discomfort (Chesney
1975). The trials included women of various ages the overall range
was 16 to 44 years of age. Common exclusion criteria were use of
oral contraceptives or intrauterine devices and use of additional
medication. Three trials mention the source of women; they were
all recruited using advertisements from the local community or
were college students (Amodei 1987; Bennink 1982; Hart 1981).
All trials took place in the USA.
Types of interventions
A number of different behavioural interventions were considered
by the five trials. Relaxation by itself or in combination with other
treatments was investigated by three trials (Amodei 1987; Bennink
1982; Chesney 1975); other investigated treatments were biofeed-
back (Bennink 1982; Hart 1981); pain management (Quillen
1982); and coping skills (Amodei 1987). The duration of treat-
ment varied from one to six months.
Types of outcomes
The primary outcome in all five trials was pain, pain relief, or relief
of symptoms. This was measured and reported in a variety of ways
(see Included Studies table for more details).
Risk of bias in included studies
See Quality Table (Table 1).
Randomisation and allocation concealment
All five trials were stated they were randomised. All received an al-
location concealment score of B due to lack of information regard-
ing how randomisation was performed and concealed (Amodei
1987; Bennink 1982; Chesney 1975; Hart 1981; Quillen 1982).
Blinding
One trial (Chesney 1975) reported it was double blind, however
blinding status was unclear as the trial only stated that both the
treatment providers and women were unaware of the purpose or
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hypothesis of the trial and did not state whether they were blind to
their treatment assignment. One trial (Amodei 1987) was single
blind (therapist only). In the remaining three trials (Bennink 1982;
Hart 1981; Quillen 1982) no specific information on blinding
was reported.
Inclusion and exclusion criteria
The inclusion and exclusion criteria were clearly defined by all
the trials. Many trials used the Menstrual Symptoms Question-
naire to place women in sub-categories of congestive or spasmodic
dysmenorrhoea either for inclusion or exclusion, or for diagnostic
purposes (Amodei 1987; Bennink 1982; Chesney 1975; Quillen
1982). It is unclear how valid and clinically useful these categories
are (Webster 1979). Most of the included trials made no mention
of the women excluded from the trial. In one trial of relaxation
therapy 7 out of 79 women were excluded, either post recruitment
or randomisation (it is unclear which), due to the use of an OCP
(Chesney 1975). A trial on pain management training gave spe-
cific details on those excluded at recruitment: 14/38 women did
not start the trial due to parity, secondary dysmenorrhoea, OCP
use, concomitant medication or inability to obtain a physician’s
statement (Quillen 1982).
Intention-to-treat and withdrawals
None of the published trials stated they performed an intention
to treat analysis. Two trials made no mention of withdrawals or
dropouts (Amodei 1987; Bennink 1982). One of these trials re-
ported two studies, no mention of withdrawals was made for ei-
ther study, however in study one the size of the degrees of freedom
in the statistical analysis suggested that not all women completed
all measures (Amodei 1987). In one trial of relaxation therapy 7/
79 women were excluded due to the use of an OCP, then a fur-
ther 3/72 (4.2%) failed to complete treatment (Chesney 1975).
In another study of biofeedback training 3/14 women (21.4%)
dropped out of the trial; the authors of the trial stated their rea-
sons for withdrawal as unrelated to the nature of the study (Hart
1981).One trial on painmanagement had a large number of drop-
outs from the original 24 women, 8 dropped out during the trial
(33.3%) 4 in the control group gave no reason, as did one in the
treatment group, one in the group failed to complete treatment
due to illness and two had delayed periods. Of those remaining
another 8/16 did not complete the 18 month follow-up as they
were either not contactable, using oral contraceptives or pregnant
(Quillen 1982).
Trial design
Two trials were of factorial design (Bennink 1982; Hart 1981).
The other trials did not explicitly state trial design.
Sample size
All trials included in the review were of relatively small sample
sizes. Sizes range from 14 to 72 women randomised in each trial.
Baseline comparison of groups
Pre-treatment symptom severity scores (SSS) for the different treat-
ment groups were presented by three trials (Chesney 1975; Hart
1981; Bennink 1982), all of these trials showed no significant dif-
ferences in baseline scores. Two trials compared Menstrual Symp-
tom Questionnaire (MSQ) scores at baseline and showed no dif-
ference (Amodei 1987; Quillen 1982).
Consistency of treatment and compliance to treatment sched-
ules
Trials that involve specific behavioural interventions can be partic-
ularly difficult to administer consistently to all the participants in
the trial. Only two of the included trials clearly mention attempts
to ensure treatment was consistent (Amodei 1987; Hart 1981).
One of these trials had a number of therapists providing treat-
ment but gave them a few hours of training and detailed manuals
to follow (Amodei 1987). The other trial had weekly meetings
for the 10 therapists providing treatment to help maintain consis-
tency and also only used male therapists to try and control for a
possible gender effect (Hart 1981). Scheduling problems with this
trial meant that not all participants received the same number of
treatments, 16 treatments per participant were intended but the
actual number of treatments ranged from 9 to 15. The other trials
appear to be consistent in their approach to treatment but there
was a lack of reported information to clearly assess this consistency.
There was no mention of any checks to ensure participants com-
plied to their assigned treatment schedule by two of the included
trials (Bennink 1982; Quillen 1982). The other trials used various
means to monitor compliance. For the biofeedback trial all the
therapy sessions were monitored, although home practice sessions
were not monitored (Hart 1981). Two trials that included a relax-
ation treatment group asked participants to maintain records of
relaxation practice (Amodei 1987; Chesney 1975).
Outcome assessment
Four of the included trials used the Symptom Severity Scale (SSS),
a 15 point rating scale developed by Chesney 1975, in most
cases this scale was well described (Amodei 1987; Bennink 1982;
Chesney 1975; Hart 1981). One trial used the Moo’s Menstrual
Distress questionnaire (MDQ) (Quillen 1982).
Timing of outcome measures was typically the menstruation fol-
lowing treatment although one trial also carried out a follow-up
18 months after treatment, which meant many of the original par-
ticipants were uncontactable (Quillen 1982).
Outcome measures were usually well reported by the trials. One
trial used the MDQ but only reported a small set of the measures,
those with large differences between the two groups (Quillen
1982).
Effects of interventions
Five trials of behavioural interventions for dysmenorrhoea met the
criteria for inclusion in the review. A number of different inter-
ventions were considered by these trials. Relaxation by itself or in
combination with other treatments was investigated by three trials
(Amodei 1987; Bennink 1982; Chesney 1975); other investigated
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treatments were biofeedback (Bennink 1982; Hart 1981); pain
management (Quillen 1982); and coping skills (Amodei 1987).
The primary outcome in all five trials was pain, pain relief, or relief
of symptoms, although this was measured and reported in a variety
of ways. Due to the heterogeneity in the considered interventions
and outcomes reported statistical pooling would have been inap-
propriate, even if possible. For this reason, the studies have been
analysed separately.
1) Behavioural interventions versus control
Pain relief
One RCT (Quillen 1982) found pain management training was
successful in reducing pain compared to a control (pain scale of
0-5, summed means with a minimum score 0, maximum score
of 25, treatment mean 2.63, control mean 7.75, reported p-value
from trial <0.002). The data from the trial were not suitable for
meta-analysis so are described in Analysis 1.1.
Overall improvement in symptoms
Two trials (Bennink 1982; Chesney 1975) reported improvement
in symptoms using the Symptom Severity Scale (a 15 item scale of
menstrual symptoms, each symptom is scored on a 1-5 point scale,
minimum score 15, maximum score 75). Neither trial showed a
statistically significant difference between the treatment and con-
trol groups for either all women with dysmenorrhoea or women
with a specific subtype of dysmenorrhoea (spasmodic or conges-
tive) (see Analysis 1.2 - Relaxation vs control WMD 3.4, 95% CI
-11.12, 17.92; Relaxation and biofeedback vs control WMD 1.4,
95% CI -10.82, 13.62; Relaxation and imagery vs control, spas-
modic women WMD -0.65, 95% CI -29.52, 28.22; Relaxation
and imagery vs control, congestive women WMD -1.55, 95% CI
-36.27, 33.17; Relaxation and imagery vs group discussion, spas-
modic women WMD -1.0, 95% CI -32.22, 30.22; Relaxation
and imagery vs group discussion, congestive women WMD -1.0,
95% CI 37.78, 35.78).
Two further trials (Amodei 1987; Quillen 1982) reported out-
comes of symptom severity. The data were not suitable for meta-
analysis so are described in Analysis 1.3. One trial reported that re-
laxationwith imagery and relaxation alone (Amodei 1987)were ef-
fective treatments for reducing symptom scores compared to a con-
trol in menstrual sufferers with spasmodic symptoms yet showed
no difference for menstrual sufferers with congestive symptoms
(no clear data other thanMANOVAF scores were presented in the
trial, see Table 0.1.06). The other trial (Quillen 1982) reported
that ’general discomfort’ was more likely to be relieved by pain
management training than a control (scale of 0-5, summed means
with a minimum score 0, maximum score of 25, treatment mean
2.75, control mean 8.38, reported p-value from trial <0.002).
Adverse effects
No included trials reported data on adverse effects of treatment.
Requirements for medication additional to assigned treatment
No included trials reported data on requirements for additional
medication.
Restriction of daily life activities
Two trials (Amodei 1987; Quillen 1982) reported restrictions in
daily life activities as a result of dysmenorrhoea. The data were not
suitable formeta-analysis so are described inAnalysis 1.4.One trial
(Amodei 1987) reported the minutes of rest women needed each
day as means. Results reported in the trial showed that women in
the relaxation group with spasmodic dysmenorrhoea had a signif-
icant decrease in their need for resting time compared to controls
(Combined relaxation group - congestives 8 minutes, spasmod-
ics: 42 minutes; Controls - congestives 15 minutes, spasmodics
58 minutes). The other trial (Quillen 1982) reported that inter-
ference in daily activities was less likely in the pain management
training group compared to a control (scale of 0-5, summedmeans
with a minimum score 0, maximum score of 25, treatment mean
1.63, control mean 4.75, reported p-value from trial <0.002).
Absence from work or school
One trial (Quillen 1982) reported the outcome of absence from
work or school as the number of minutes of ’lost time’. Results
showed a statistically significant result suggesting that pain man-
agement training resulted in less time absent from school or work
compared to a control (Analysis 1.5; WMD -313.12, 95% CI -
470.69, -155.55).
2) Behavioural interventions vs behavioural interventions
Pain relief
No included trials reported data on pain relief.
Overall improvement in symptoms
Two trials (Bennink 1982; Hart 1981) reported improvement in
symptoms using the Symptom Severity Scale (a 15 item scale of
menstrual symptoms, each symptom is scored on a 1-5 point scale,
minimum score 15, maximum score 75). Neither trial showed a
statistically significant difference between the treatment groups
(Biofeedback with EMG vs biofeedback with skin temperature
trainingWMD -4.0, 95%CI -9.25, 1.25; Relaxation and biofeed-
back vs relaxationWMD-2.0, 95%CI 14.93, 10.93). See Analysis
2.1
One trial (Amodei 1987) reported the measurement of symptom
severity scores. The data were not suitable for meta-analysis so are
described in Analysis 2.2. This trial reported that both relaxation
with imagery and relaxation alone were effective treatments for
reducing symptom scores in menstrual sufferers with spasmodic
symptoms yet showed no difference for menstrual sufferers with
congestive symptoms (no clear data other thanMANOVAF scores
were presented in the trial, see Table 0.1.06). The second experi-
ment reported by this trial compared relaxation and coping skills
with coping skills alone. The trial did not report any data for
this experiment and reported that ’multivariate analysis failed to
demonstrate any significant effects’.
Adverse effects
No included trials reported data on adverse effects of treatment.
Requirements for medication additional to assigned treatment
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No included trials reported data on requirements for additional
medication.
Restriction of daily life activities
One trial (Amodei 1987) reported the minutes of rest women
needed each day as means. Results reported in the trial (Analysis
2.3) showed that women in the relaxation group with spasmodic
dysmenorrhoea had a significant decrease in their need for resting
time compared to the relaxation and imagery group following two
cycles of treatment (Relaxation with imagery group - 44 minutes,
relaxation alone 15.7 minutes, no reported p-value). The second
experiment reported by this trial compared relaxation and coping
skills with coping skills alone. The trial did not report any data
for this experiment and reported that ’multivariate analysis failed
to demonstrate any significant effects’.
Absence from work or school
No included trials reported data on absence from work or school.
D I S C U S S I O N
The aim of this review was to investigate the effectiveness of any
behavioural interventions for the treatment of primary or sec-
ondary dysmenorrhoea when compared to each other, placebo, no
treatment or conventional medical treatments (e.g. NSAIDs). A
meta-analysis combining results from all the trials was not feasible
due to differences in the measurement, timing and reporting of
outcomes. In addition a number of trials failed to report data on
all the outcomes they claimed to measure. This may be a result
of trials only reporting ’significant’ results and is a form of publi-
cation bias that may impact on the overall results of this review.
Due to difficulties with the available data results were reported as
dichotomous, continuous or descriptive data separately.
Only five relevant trials were identified and included in this re-
view. Interventions included relaxation training with and with-
out imagery, relaxation plus biofeedback, biofeedback with EMG
training, and pain management sessions.
The trials in this review had variable quality ratings. None of the
trials were clear about how treatment allocation was concealed.
Only one of the trials (Chesney 1975) was double blind and one
was single blind (Amodei 1987). To be successful in maintaining
blinding, the women entering the trial need to be unsure of the
treatment being offered. This was unclear in the two trials that
mentioned blinding. Double blinding in behavioral interventions
is also generally considered impossible, as the treatment provider
needs to physically deliver the treatment. As a result, it is probably
impossible to perform a true double blind trial of a behavioural
intervention although blinding of the participant and outcome
assessors should be used if possible. Most of the trials in this review
used waiting list controls. An important aspect when using waiting
list as controls is the women’s previous experience with treatment.
Previous treatment of the women was not mentioned in any of the
trials in this review.
Women with different levels of severity of dysmenorrhoea were
included in the trials and different ways of assessing pain or pain
relief were also used. Follow-up length and the timing of outcome
assessment also differed.
Overall, the trials in this review had small sample sizes and were of
poor methodological quality. Therefore no strong conclusion can
be made due to the small size of the trials and other methodologi-
cal considerations. There were also methodological problems asso-
ciated with the initial diagnosis of dysmenorrhoea .The use of the
Menstrual SymptomQuestionnaire (MSQ) to diagnose categories
of congestive (dull, aching pain) or spasmodic (acute, colicky pain)
dysmenorrhoea are categories that are no longer widely used in
experimental trials due to limited validity. There were problems
associated with quantifying and grading the pain of dysmenor-
rhoea in the included trials. The assessment instruments used in
quantifying dysmenorrhoea are based on women’s self report and
as such are subject to obvious bias. In addition all the trials cate-
gorised pain using different scales.
Overall there were few withdrawals from treatment, but reporting
of adverse events was not conducted by any of the studies therefore
it is clear that the data presented in the studies does not reflect a
comprehensive assessment of adverse events.
Treatment providers performbehavioural therapies with variation.
Treatment is often individually tailored to each participants set of
symptoms. Even if this is not the case, different therapists vary
the duration of treatment, the frequency of treatments, timing of
treatments in the cycle and the number of treatments performed.
These are all factors that make it difficult to assess the overall
efficacy of behavioural interventions. The impact of these factors
on treatment outcome is not clear.
In the trials included in this review, there were many differences
in treatment schedules. Many treatments were scheduled during
menses, however other trials carried out interventions anytime in
the menstrual cycle. These different approaches could affect the
measurement of outcomes.
Menstrual pain is highly predictable and has a brief episodic course
so seems well-suited to behavioural interventions that can be self-
managed. While the trials in this review failed to demonstrate a
clear efficacy of behavioural interventions their usefulness should
be further evaluated.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is some evidence from five RCTs that behavioural interven-
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tions may be effective for dysmenorrhoea. However results should
be viewed with caution as they varied greatly between trials due
to inconsistency in the reporting of data, small trial size, poor
methodological quality and age of the trials.
Implications for research
The trials included in this study that look at behavioural inter-
ventions that are all at least 20 years old therefore more recent
trials would be useful. Comparisons with other standard medical
treatments such as nonsteroidal anti-inflammatories would also
be useful. Any future trials would need to be randomised con-
trolled trials with adequate sample sizes. Objective pain outcome
measures such as the visual analogue scale should also be used to
standardised outcome trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Amodei 1987
Methods Randomisation method: not stated.
Design: factorial
Blinding: Single blind, therapists blind to experimental hypotheses and participant assign-
ment
Number of women randomised: n= 88women interviewed and randomised( 33 spasmodics
and 29 congestives)
Number of withdrawals:n= 26 (29.5%)
No power calculation or intention to treat analysis performed.
Source of funding: not stated
Intervention 1:Participants matched on severity of symptoms and randomly assigned to
two groups
Intervention 2: participant selection same as intervention 1
29 congestives from intervention 1, and 18 additional congestive women recruited.
assignment.
Participants Inclusion: regular cycles, premenstrual or menstrual discomfort for at least two years,
women classified as spasmodic or congestive according toMenstrual Distress Questionnaire
scores.
Exclusion: pregnant, psychological disorders.
Age: mean of spasmodic group 20.3, mean of congestive group 30.5.
Source of participants: introductory psychology classes, local community.
Location: North Carolina, USA.
Interventions Intervention 1:
1. relaxation training plus imagery ( 5 individual treatment sessions), n=12 spasmodics
2. relaxation training only (same as above), n=11 spasmodics and 12 congestives.
3. waiting list control (collected data for 3 consecutive menses), n=10 spasmodics and 17
congestives.
Intervention 2:
1. coping skills only (“brief training” in behavioral-cognitive skills), n=10 congestives
2. coping skills plus relaxation training, n=8 congestives
3. relaxation only and waiting list groups from experiment 1 were also used in data analysis.
Duration: 5 cycles
Outcomes Symptom Severity Scale
Ratings of pain/physical discomfort on 0-100 scale
Number of minutes engaged in “resting” behavior
Number of doses of analgesia
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Amodei 1987 (Continued)
Allocation concealment (selection bias) Unclear risk B - Unclear
Bennink 1982
Methods Randomisation method: not stated
Design: factorial
Blinding: no
Number of women randomised: n= 15 (randomized comparison between 3 groups (2
treatment and 1 control)
Number of withdrawals: none
Power calculation: no
Intention to treat analysis: no
Funding: not stated
Participants Inclusion: women with spasmodic dysmenorrhoea as indicated by the Menstrual Distress
Questionnaire, moderate to severe dysmenorrhoea on Symptom Severity Scale, moderate
to severe menstrual cramping.
Exclusion: organic disease, use of oral contraceptives, use of medication during study.
Age: mean 19.2
Source of participants: volunteer college students
Location: Michigan, USA.
Interventions Intervention 1: relaxation plus biofeedback (n=5) in 5 30 min sessions
Intervention 2: relaxation only (n=5) as above but with no feedback
Intervention 3: control/no treatment (n=5) told to wait for next menses
Duration : at least 3 consecutive menstrual cycles.
All subjects received a relaxation/biofeedback type session after initial interview, treatment
then began at the next cycle
Outcomes Daily Intensity Rating: abdominal cramping intensity on a 5 point scale
Symptom Severity Inventory
EMG (electromyographic) Ratings - graphic representation of muscle contractions
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B - Unclear
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Chesney 1975
Methods Randomisation method: not stated
Design: not stated
Blinding: unclear, trial states that therapist and participants unaware of purpose or hy-
potheses of trial
Number of women randomised: n= 72 (random allocation of women in blocks of 3, women
rank ordered according to symptom severity then each block of 3 randomised into the 3
treatments).
Number of withdrawals: n= 10 (12.6%)7 excluded due to use of OCP and 3 did not
complete
Power calculation: no
Intention to treat analysis: no
Funding: not stated
Participants Inclusion: women with menstrual discomfort, non parous.
Exclusion: OCP use
Age: 19.7 years
Location: Colorado State University, USA.
Interventions Intervention 1: behaviour therapy with female undergraduate psychology student: relax-
ation procedures, deep muscle relaxation exercises, visual imagery taught over 5 sessions
Intervention 2: pseudo-treatment (leaderless group discussion): 5 sessions of self-directed
group discussion
Intervention 3: waiting list: letter asking for symptom questionnaire to facilitate entry into
next group.
Duration: 5 weeks
Outcomes Symptom Severity Score scale
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B - Unclear
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Hart 1981
Methods Randomisation method: allocation not stated, women randomly assigned by pairs matched
on menstrual distress and symptom severity scores
Design: 2 x 3 split plot factorial design
Blinding: no
Number of women randomised: n= 14 ( 11 analysed, 3 dropouts for reasons unrelated to
the nature of the study)
Number of withdrawals: n=3 (21%)
Power calculation: no
Intention to treat analysis: no
Funding: not stated
Participants Inclusion: primary dysmenorrhoea.
Age: mean 26.9
Parity: 10/11 women were nulliparous Source: volunteers from adverts at campus and in
local newspapers
Interventions Intervention 1: biofeedback training with EMG training of the frontalis muscle.
Intervention 2: biofeedback training with skin temperature training of the frontalis muscle.
Treatments began after day 5 of 2nd cycle; 30 minute sessions; 16 sessions over 2 cycles
designed but unable to be completed (mean # sessions 12.9); home practice of biofeedback.
Duration: 2 months baseline, 2 months biofeedback training, two months follow up data
collection.
10 male doctoral students in psychology did training
Outcomes SymptomSeverity Scale administered after eachmenstrual cycle and for 2months following
treatment cycles
Notes a LOT of therapists for only 14 patients!
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B - Unclear
Quillen 1982
Methods Randomisation method: allocation not stated, participants blocked into pairs based on
symptoms and then each pair randomly assigned to treatment control groups
Design: not stated
Blinding: not stated
Number of women randomised: n=24
Number of withdrawals: 8 (33%)
Power calculation: no
Intention to treat analysis: no
Funding: not stated
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Quillen 1982 (Continued)
Participants Inclusion: severe primary dysmenorrhoea, grouped as spasmodic or congestive according
to Menstrual Symptom Questionnaire
Exclusion: parous, secondary dysmenorrhoea, use of OCP, unwilling to obtain MDs veri-
fication of primary dysmenorrhoea, use of prescription drugs for dysmenorrhoea.
Location: USA.
Interventions Intervention: four two hour individual pain management sessions, one week apart between
2nd and 3rd periods for treatment group.
Control subjects were not contacted at this same point having been told it was a longitudinal
study with longer follow up.
Duration: not stated
Outcomes Pre-treatment: Menstrual Symptom Questionnaire and Menstrual Distress Questionnaire,
and with Daily Record of Menstrual Complaints
Post treatment: Daily records and Menstrual distress questionnaire completed after 3rd
period (THIS IS CONFUSING because it also says controls were not contacted after 3rd
period???)




Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B - Unclear
OCP= oral contraceptive pill
NSAIDS= non-steroidal anti-inflammatory drugs
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Hubbell 1949 Exercise intervention
Israel 1985 Exercise intervention
Lundquist 1947 Exercise intervention
Mathur 1986 Not randomised
Pearce 1982 Trial investigated at pelvic pain rather than dysmenorrhoea
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(Continued)
Peters1991 Trial investigated general pelvic pain rather than dysmenorrhoea
Sigmon 1988 Not randomised
Van Zak 1994 Trial investigated premenstrual syndrome not dysmenorrhoea
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D A T A A N D A N A L Y S E S
Comparison 1. Behavioural intervention versus control




participants Statistical method Effect size
1 Pain relief - descriptive data Other data No numeric data
2 Improvement in symptoms -
measured by Symptom Severity
Scale
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Relaxation vs control 1 10 Mean Difference (IV, Fixed, 95% CI) 3.40 [-11.12, 17.92]
2.2 Relaxation & biofeedback
vs control
1 10 Mean Difference (IV, Fixed, 95% CI) 1.40 [-10.82, 13.62]
2.3 Relaxation and imagery vs
control - spasmodic dys
1 24 Mean Difference (IV, Fixed, 95% CI) -0.65 [-29.52, 28.
22]
2.4 Relaxation and imagery vs
control - congestive dys
1 22 Mean Difference (IV, Fixed, 95% CI) -1.55 [-36.27, 33.
17]
2.5 Relaxation and imagery vs
group discussion - spasmodic
dys
1 24 Mean Difference (IV, Fixed, 95% CI) -1.0 [-32.22, 30.22]
2.6 Relaxation and imagery
vs group discussion- congestive
dys
1 22 Mean Difference (IV, Fixed, 95% CI) -1.0 [-37.78, 35.78]
3 Improvement in symptoms-
descriptive data
Other data No numeric data
4 Restrictions in activities of daily
living - descriptive data
Other data No numeric data
5 Absence from work or school -
continuous data (minutes of
lost time)
1 16 Mean Difference (IV, Fixed, 95% CI) -313.12 [-470.69, -
155.55]
5.1 Pain management training
vs control
1 16 Mean Difference (IV, Fixed, 95% CI) -313.12 [-470.69, -
155.55]
Comparison 2. Behavioural intervention vs other behavioural intervention




participants Statistical method Effect size
1 Improvement in symptoms -
measured by Symptom Severity
Scale
2 21 Mean Difference (IV, Fixed, 95% CI) -3.72 [-8.58, 1.15]
1.1 Biofeedback with EMG
vs biofeedback with skin temp
training
1 11 Mean Difference (IV, Fixed, 95% CI) -4.0 [-9.25, 1.25]
1.2 Relaxation & biofeedback
vs Relaxation
1 10 Mean Difference (IV, Fixed, 95% CI) -2.0 [-14.93, 10.93]
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2 Improvement in symptoms-
descriptive data
Other data No numeric data
3 Restrictions in activities of daily
living - descriptive data
Other data No numeric data
Analysis 1.1. Comparison 1 Behavioural intervention versus control, Outcome 1 Pain relief - descriptive
data.
Pain relief - descriptive data
Study Comparisons n Outcome measure-
ment
Data Conclusions (trial)
Quillen 1982 1) Pain management
training
2) Waiting list con-
trol
16, 8 in each treat-
ment group
Pain - scale 0-5 (none
to exceptionally
great). Means and std
dev for the sum of re-
sponses over 5 days
reported for 3 cycles
and at 18 month fol-
low-up (min 0-max
25)
Cycle 3 (n=8 in each
group):
Treatment - 2.63 (1.
19)
Control - 7.75 (3.15)
18mth follow-up (n=
4 in each group):
Treatment - 3.5 (1.
73)
Control - 8.75 (1.26)
Trial reported that:




controls on all out-
come measures (p<0.
002)
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Analysis 1.2. Comparison 1 Behavioural intervention versus control, Outcome 2 Improvement in
symptoms - measured by Symptom Severity Scale.
Review: Behavioural interventions for dysmenorrhoea
Comparison: 1 Behavioural intervention versus control
Outcome: 2 Improvement in symptoms - measured by Symptom Severity Scale





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Relaxation vs control
Bennink 1982 5 39.6 (12.2) 5 36.2 (11.2) 100.0 % 3.40 [ -11.12, 17.92 ]
Subtotal (95% CI) 5 5 100.0 % 3.40 [ -11.12, 17.92 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
2 Relaxation % biofeedback vs control
Bennink 1982 5 37.6 (8.3) 5 36.2 (11.2) 100.0 % 1.40 [ -10.82, 13.62 ]
Subtotal (95% CI) 5 5 100.0 % 1.40 [ -10.82, 13.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.82)
3 Relaxation and imagery vs control - spasmodic dys
Chesney 1975 12 41.83 (28.5) 12 42.48 (42.33) 100.0 % -0.65 [ -29.52, 28.22 ]
Subtotal (95% CI) 12 12 100.0 % -0.65 [ -29.52, 28.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.96)
4 Relaxation and imagery vs control - congestive dys
Chesney 1975 11 43.09 (40.91) 11 44.64 (42.18) 100.0 % -1.55 [ -36.27, 33.17 ]
Subtotal (95% CI) 11 11 100.0 % -1.55 [ -36.27, 33.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.93)
5 Relaxation and imagery vs group discussion - spasmodic dys
Chesney 1975 12 41.83 (28.5) 12 42.83 (47.25) 100.0 % -1.00 [ -32.22, 30.22 ]
Subtotal (95% CI) 12 12 100.0 % -1.00 [ -32.22, 30.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
6 Relaxation and imagery vs group discussion- congestive dys
Chesney 1975 11 43.09 (40.91) 11 44.09 (46.91) 100.0 % -1.00 [ -37.78, 35.78 ]
Subtotal (95% CI) 11 11 100.0 % -1.00 [ -37.78, 35.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Chi2 = 0.16, df = 5 (P = 1.00), I2 =0.0%
-100 -50 0 50 100
Favours treatment Favours control
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Analysis 1.3. Comparison 1 Behavioural intervention versus control, Outcome 3 Improvement in
symptoms- descriptive data.
Improvement in symptoms- descriptive data
Study Comparisons n Outcome measure-
ment
Data Conclusions (trial)
Amodei 1987 Experiment 1:
1) Relaxation & im-
agery
2) Relaxation













1, and 18 additional
congestivewomen re-
cruited
No data presented in
the trial.
MANOVA F scores
and p values the only
data given.
Experi-
ment 1: MANOVA -
3 treatment x 3 mea-
surement occasions -
F (8,116) = 2.62, p
<0.01;MANOVA - 2
subject types, conges-
tive and spasmodic x
2 treatments x 3mea-
surement occasions -
F (4,43) = 3.33, p<0.
02 and F (4,43) = 4.
32, p<0.005
There was some re-
duction in symptom
severity for all exper-
imental positions
Quillen 1982 1) Pain management
training
2) Waiting list con-
trol
n=16, 8 women in
each group
General discomfort
measured on scale 0-
5, none- exception-
ally great. Data re-
ported as means (std
dev) of sum of partic-
ipants responses for
five days (min 0- max
25)
Cycle 3 (n=8 women
in each group):
Treatment - 2.75 (1.
04)
Control - 8.38 (1.3)
18 month Follow-up
(n=4 women in each
group)
Treatment - 4.25 (1.
71)
Control - 8.25 (1.26)
Trial reported that:




controls on all out-
come measures (p<0.
002)
Analysis 1.4. Comparison 1 Behavioural intervention versus control, Outcome 4 Restrictions in activities of
daily living - descriptive data.
Restrictions in activities of daily living - descriptive data
Study Comparisons n Outcome measure-
ment
Data Conclusions (trial)
Amodei 1987 Experiment 1:
1) Relaxation & im-
agery
2) Relaxation












1, and 18 additional
congestivewomen re-
Minutes needing to




gestives 28 mins pre-
treatment, 8minpost







in their need for rest-
ing time
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Restrictions in activities of daily living - descriptive data (Continued)
coping skills cruited pretreatment, 42
mins post treatment
1, 16 mins post treat-
ment 2
Controls: Conges-
tives - 32 mins pre-
treatment, 15 mins
post treatment 1, 18
mins post treatment
2. Spasmodics - 49
min pretreatment, 58
mins post treatment
1, 95 mins post treat-
ment 2
Quillen 1982 1) Pain management
training
2) Waiting list con-
trol




ally great. Data re-
ported as means (std
dev) of sum of partic-
ipants responses for
five days (min 0- max
25)
Cycle 3 (n=8 women
in each group):
Treatment - 1.63 (1.
06)Control - 4.75 (1.
91)
18 month Follow-up
(n=4 women in each
group)
Treatment - 2.0 (1.
83)
Control - 3.25 (2.36)
Trial reported that:




controls on all out-
come measures (p<0.
002)
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Analysis 1.5. Comparison 1 Behavioural intervention versus control, Outcome 5 Absence from work or
school - continuous data (minutes of lost time).
Review: Behavioural interventions for dysmenorrhoea
Comparison: 1 Behavioural intervention versus control
Outcome: 5 Absence from work or school - continuous data (minutes of lost time)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pain management training vs control
Quillen 1982 8 80.63 (87.61) 8 393.75 (209.84) 100.0 % -313.12 [ -470.69, -155.55 ]
Total (95% CI) 8 8 100.0 % -313.12 [ -470.69, -155.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 2.1. Comparison 2 Behavioural intervention vs other behavioural intervention, Outcome 1
Improvement in symptoms - measured by Symptom Severity Scale.
Review: Behavioural interventions for dysmenorrhoea
Comparison: 2 Behavioural intervention vs other behavioural intervention
Outcome: 1 Improvement in symptoms - measured by Symptom Severity Scale





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Biofeedback with EMG vs biofeedback with skin temp training
Hart 1981 5 32.8 (3.4) 6 36.8 (5.4) 85.9 % -4.00 [ -9.25, 1.25 ]
Subtotal (95% CI) 5 6 85.9 % -4.00 [ -9.25, 1.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
2 Relaxation % biofeedback vs Relaxation
Bennink 1982 5 37.6 (8.3) 5 39.6 (12.2) 14.1 % -2.00 [ -14.93, 10.93 ]
Subtotal (95% CI) 5 5 14.1 % -2.00 [ -14.93, 10.93 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Total (95% CI) 10 11 100.0 % -3.72 [ -8.58, 1.15 ]
Heterogeneity: Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 0.08, df = 1 (P = 0.78), I2 =0.0%
-10 -5 0 5 10
Favours intervention 1 Favours intervention 2
Analysis 2.2. Comparison 2 Behavioural intervention vs other behavioural intervention, Outcome 2
Improvement in symptoms- descriptive data.
Improvement in symptoms- descriptive data
Study Comparisons n Outcome measure-
ment
Data Conclusions (trial)
Amodei 1987 Experiment 1:
1) Relaxation & im-
agery
2) Relaxation













1, and 18 additional
congestivewomen re-
cruited
No data presented in
the trial.
MANOVA F scores
and p values the only
data given.
Experi-
ment 1: MANOVA -
3 treatment x 3 mea-
surement occasions -
F (8,116) = 2.62, p
<0.01;MANOVA - 2
subject types, conges-
tive and spasmodic x
2 treatments x 3mea-
surement occasions -
F (4,43) = 3.33, p<0.
There was some re-
duction in symptom
severity for all exper-
imental positions
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Improvement in symptoms- descriptive data (Continued)
02 and F (4,43) = 4.
32, p<0.005
Analysis 2.3. Comparison 2 Behavioural intervention vs other behavioural intervention, Outcome 3
Restrictions in activities of daily living - descriptive data.
Restrictions in activities of daily living - descriptive data
Study Comparisons n Outcome measure-
ments
Data Conclusions (trial)
Amodei 1987 Experiment 1:
1) Relaxation & im-
agery
2) Relaxation


































in their need for rest-
ing time
A D D I T I O N A L T A B L E S















Not stated Factorial B Single (ther-
apist)
No No 26 (29.5%) Not stated
Bennink
1982
Not stated Factorial B No No No None Not stated
Chesney
1975
Not stated Not stated B Double No No 10 (12.6%) Not stated
Hart 1981 Not stated Factorial B No No No 3 (21.4%) Not stated
Quillen
1982
Not stated Not stated B No No No 8 (33%)
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A P P E N D I C E S
Appendix 1. MDSG search terms
MW527 MDSG Search string 15.05.09
Keywords CONTAINS “dysmenorrhoea” or “dysmenorrhoea” or “Dysmenorrhea-Symptoms” or “menstrual cramps” or “menstrual
pain” or “pain-dysmenorrhea” or “pelvic pain” or Title CONTAINS“dysmenorrhoea” or “dysmenorrhoea” or “Dysmenorrhea-Symp-
toms” or “menstrual cramps” or “menstrual pain” or “pain-dysmenorrhea” or “pelvic pain”
AND
Keywords CONTAINS “behavioral coping strategies” or “behavioral therapy” or “cognitive behavioral therapy” or “cognitive ap-
proaches” or “cognitive coping strategies” or “coping strategies” or “Relaxation Techniques” or “Psychological therapies” or “psycholog-
ical therapy” or “psychophysiological” or “psychosocial therapy” or “Psychotherapy” or “biofeedback” or “electromyography” or Title
CONTAINS “behavioral coping strategies” or “behavioral therapy” or “cognitive behavioral therapy” or “cognitive approaches” or
“cognitive coping strategies” or “coping strategies” or “Relaxation Techniques” or “Psychological therapies” or “psychological therapy”
or “psychophysiological” or “psychosocial therapy” or “Psychotherapy” or “biofeedback” or “electromyography”
Appendix 2. MEDLINE search strategy





3 painful menstrua$.tw. (65)
4 pelvic pain/ (2282)
5 menstrua$ cramp$.tw. (76)
6 (menstrua$ adj3 pain$).tw. (597)
7 pelvic pain.tw. (3827)
8 or/1-7 (8244)
9 Complementary Therapies/ (10571)
10 “Biofeedback (Psychology)”/ (5238)
11 DESENSITIZATION, PSYCHOLOGIC/ (1427)
12 (behavioural adj5 therapy).tw. (1231)
13 Behavior Therapy/ (19972)
14 Cognitive Therapy/ (9156)
15 PSYCHOTHERAPY/ (35506)
16 Psychotherapy, Rational-Emotive/ (165)












29 8 and 28 (301)
30 randomized controlled trial.pt. (270500)
31 controlled clinical trial.pt. (79176)
32 randomized.ab. (180480)
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33 placebo.tw. (115211)
34 clinical trials as topic.sh. (143058)
35 randomly.ab. (130974)
36 trial.ti. (78769)
37 (crossover or cross-over or cross over).tw. (42715)
38 or/30-37 (640944)
39 (animals not (humans and animals)).sh. (3278689)
40 38 not 39 (593527)
41 40 and 29 (29)
42 (2005$ or 2006$ or 2007$ or 2008$ or 2009$).ed. (2994237)
43 42 and 41 (15)
44 from 43 keep 1-15 (15)
Appendix 3. CENTRAL search strategy





3 painful menstrua$.tw. (6)
4 pelvic pain/ (162)
5 menstrua$ cramp$.tw. (15)
6 (menstrua$ adj3 pain$).tw. (121)
7 pelvic pain.tw. (313)
8 or/1-7 (893)
9 Complementary Therapies/ (133)
10 “Biofeedback (Psychology)”/ (606)
11 DESENSITIZATION, PSYCHOLOGIC/ (260)
12 (behavioural adj5 therapy).tw. (427)
13 Behavior Therapy/ (2296)
14 Cognitive Therapy/ (2249)
15 PSYCHOTHERAPY/ (1012)
16 Psychotherapy, Rational-Emotive/ (19)












29 8 and 28 (23)
30 limit 29 to yr=“2005 -Current” (9)
31 from 30 keep 1-9 (9)
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Appendix 4. EMBASE search strategy
Database: EMBASE <1980 to 2009 Week 19>
Search Strategy:
--------------------------------------------------------------------------------
1 Controlled study/ or randomized controlled trial/ (2899215)
2 double blind procedure/ (72374)
3 single blind procedure/ (8152)
4 crossover procedure/ (21275)
5 drug comparison/ (81258)
6 placebo/ (126465)
7 random$.ti,ab,hw,tn,mf. (438069)




12 ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).ti,ab,hw,tn,mf. (118808)
13 (comparative adj5 trial$).ti,ab,hw,tn,mf. (16000)
14 (clinical adj5 trial$).ti,ab,hw,tn,mf. (608295)
15 or/1-14 (3434891)
16 nonhuman/ (3221437)
17 animal/ not (human/ and animal/) (14488)
18 or/16-17 (3225137)
19 15 not 18 (2029152)
20 dysmenorrh$.tw. (2221)
21 dysmenorrhea/ (3676)
22 (painful adj5 menstruat$).tw. (44)
23 pelvic pain/ (4775)
24 or/20-23 (8360)





30 Cognitive Therapy/ or Behavior Therapy/ (27717)
31 Cognitive Therapy/ (16130)
32 PSYCHOTHERAPY/ (37185)
33 emotive therapy/ (19)
34 rational-emotive therapy.tw. (93)






41 19 and 24 and 40 (121)
42 limit 41 to yr=“2008 -Current” (17)
43 from 42 keep 1-17 (17)
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Appendix 5. psycINFO search strategy





3 painful menstrua$.tw. (13)
4 pelvic pain/ (0)
5 menstrua$ cramp$.tw. (11)
6 (menstrua$ adj3 pain$).tw. (133)
7 pelvic pain.tw. (256)
8 or/1-7 (608)
9 Complementary Therapies/ (0)
10 “Biofeedback (Psychology)”/ (0)
11 DESENSITIZATION, PSYCHOLOGIC/ (0)
12 (behavioural adj5 therapy).tw. (1188)
13 Behavior Therapy/ (11284)
14 Cognitive Therapy/ (10253)
15 PSYCHOTHERAPY/ (33451)
16 Psychotherapy, Rational-Emotive/ (0)












29 8 and 28 (72)
30 limit 29 to yr=“2005 -Current” (3)
31 from 30 keep 1-3 (3)
WH A T ’ S N E W
Last assessed as up-to-date: 3 August 2009.
Date Event Description
25 August 2011 Amended Minor edits: study numbers and search dates corrected, analyses renumbered and
linked, duplicate data in analysis tables deleted
9 February 2011 Review declared as stable The findings of this review have been deemed to be stable, therefore this review will
no longer be updated
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H I S T O R Y
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Date Event Description
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Title changed to remove ’primary and secondary’ dysmenorrhoea from the title.
N O T E S
The findings of this review have been deemed to be stable therefore this review will no longer be updated
I N D E X T E R M S
Medical Subject Headings (MeSH)
Adaptation, Psychological; Behavior Therapy [∗methods]; Biofeedback, Psychology; Dysmenorrhea [psychology; ∗therapy]; Imagery
(Psychotherapy); Randomized Controlled Trials as Topic; Relaxation Therapy
MeSH check words
Female; Humans
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